Posts by Site Maintainer
Chart: Potential impact of a host response gene expression sepsis assay (septicyte rapid) in a tertiary emergency department setting
This chart will be presented by Immunexpress collaborators from Cone Health, Greensboro, NC. at the CHEST Annual Meeting in Honolulu, October on October 10th, 2023. CHEST SeptiCyte Chart for the 2023 CHEST annual meeting (downloadable, screen-readable pdf)
Read MoreRollie Carlson joins the Med-Tech podcast to discuss early diagnosis of sepsis
Med-Tech’s Ian Bolland interviewed Rollie Carlson, CEO of Immunexpress, about the challenges of diagnosing sepsis and the technology that is being developed to tackle it.
Read MoreSeptiCyte® RAPID Receives ICD-10-PCS Code from the U.S. Centers for Medicare & Medicaid Services (CMS)
This post originally appeared on Cision PR Newswire ICD-10-PCS code to provide accurate documentation of sepsis diagnosis for medical claims using SeptiCyte® RAPID SEATTLE and BRISBANE, Australia, Sept. 6, 2023 /PRNewswire/ — Immunexpress, Pty Ltd., a molecular diagnostics company focused on improving outcomes for suspected sepsis patients, today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) has…
Read More